Alterity Therapeutics Presents New Data from ATH434 Phase 2 Trial
10 Apr 2025 //
GLOBENEWSWIRE
Alterity Therapeutics to Present Positive ATH434 Phase 2 Results
03 Apr 2025 //
GLOBENEWSWIRE
Alterity Reports Positive Interim Data For ATH434 In MSA Trial
17 Jul 2024 //
GLOBENEWSWIRE
Alterity Shows ATH434 Potential in Friedreich`s Ataxia
29 Apr 2024 //
GLOBENEWSWIRE
Alterity Therapeutics Presents New Data at World Orphan Drug Congress
10 Apr 2024 //
GLOBENEWSWIRE